State-of-the-art R&D lab expands technical feasibility capabilities for long-acting delivery of small molecules, biologics, nucleotides
Pegfilgrastim has estimated annual sales of USD 3.66 billion in the U.S. (IQVIA MAT December 2020).
Acquisition of A&C expands Aceto’s Western manufacturing footprint
This acquisition marks PPS’ foray into the development and manufacturing of peptide APIs
Pharma industry is ready to embrace technology platforms with a keen focus on automation in manufacturing and digital health investment.
WACKER and Helixmith plan to strategically collaborate on the production of a pDNA gene therapy developed by Helixmith for the treatment of diabetic peripheral neuropathy (DPN).
Subscribe To Our Newsletter & Stay Updated
